Ascendia

  MARKET NEWS

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial for Treatment of Patients With Glioblastoma
Nanoform Collaborates With Takeda on Plasma-Derived Therapy Development
Abata Therapeutics Announces Strategic Investment From Bristol Myers Squibb
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
Denali Therapeutics Announces Publication  Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS & Muscle Following Intravenous Administration
Nuntius Therapeutics Announces Collaboration With Taiho Pharmaceutical to Develop Next-Generation mRNA Therapies Using Nuntius’ Proprietary Cell-Specific Delivery Technology
Prota Therapeutics Announces Publication of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome
Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based Vaccines
Veralox Therapeutics Announces EMA Orphan Drug Designation
Immutep Announces First Participant Dosed in Phase 1 Study of First in Class Agonist LAG-3 Antibody

  EXPERT CONTENT & RESOURCES

Presentation: Strategies for Amorphous Solid Dispersion Product Development

Presentation: Strategies for Amorphous Solid Dispersion Product Development

In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design…..

ALBA SUCCESS CASE

Container Selection for a Highly Sensitive Drug Product: A Success Story

For new drug products, it is essential that pharmaceutical companies utilize the experience of container suppliers as early as possible.

Meet Gaelic Laboratories, Your Trusted Testing & Manufacturing Partner

Meet Gaelic Laboratories, Your Trusted Testing & Manufacturing Partner

Gaelic Laboratories today announces its new website, which contains details about this world-class Beta-Lactam (penicillin) manufacturer’s….

  FEATURED EDITORIAL

  COMPANY PROFILE

BASF Pharma Solutions is a leading provider of innovative and high-quality excipients and APIs for the pharmaceutical industry. Our dedicated team of industry experts, supported by our cutting-edge digital solutions, works closely with customers to develop efficient and reliable formulations. Based in Florham Park, United States, our operations span across the globe, with production facilities that spread across multiple continents, we are able to provide support and solutions to pharmaceutical industries worldwide. At BASF, we prioritize the production of pharmaceutical ingredients in accordance with the highest quality standards. With over 75 years of experience, we offer the expertise and continuity necessary to meet the diverse needs of your pharmaceutical business. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR - Development of Orally Delivered GLP-1 Therapeutics…From Diabetes to Obesity and Beyond

WEBINAR - Development of Orally Delivered GLP-1 Therapeutics…From Diabetes to Obesity and Beyond

Join Quotient Sciences’ experts on July 18 as we explore the latest developments in orally-delivered GLP-1 agonists, the potential for these therapeutics and overcoming the manufacturing challenges.

  WHITEPAPERS & WEBINARS

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

By: Jasmine Musakhanian, Senior Scientific Director, Gattefossé

INTRODUCTION

Mono and diglycerides, also known as partial glycerides, are versatile lipid excipients that play a pivotal role in the realization of drug products and nutraceuticals. Some well-known excipients in this category are …

WHITEPAPER - A Holistic Approach to Getting the First Batch Right

WHITEPAPER - A Holistic Approach to Getting the First Batch Right

By: Mark Rauckhorst, Director Supply Chain and Project Management, Vetter Development Service USA. Inc.

Clinical trials are high-visibility milestones for investors, as this is often the first major step toward financial return on what has likely been years of investment …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

August 28 – Gene Therapy
September 4 – API Synthesis